N/A
N=32
Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis
Cystic Fibrosis
Bottom Line
View on ClinicalTrials.gov: NCT02083263 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcome: Primary: Lung Function: Lung Clearance Index — 9; 9.7 lung clearance index
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Bilevel (Device); PEP mask (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Karolinska University Hospital
- Primary completion
- Sep 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Lung Function: Lung Clearance Index |
9; 9.7 | — |
| SECONDARY Blood Gases:1 Month After Chest Physiotherapy Will Take Blood Gases (Kpa). |
— | — |
Summary
With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).
Eligibility Criteria
Inclusion Criteria
- Patients with CF older than 18 years
- FEV1 between 20% and 69% of predictive.
- No acute exacerbation.
- No Burkhordelia Cepacia/MRSA colonization.
Exclusion Criteria
- Children under 18 year
- acute exacerbation.
Data sourced from ClinicalTrials.gov (NCT02083263). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.